Peginterferon-based therapies
Chronic Hepatitis B (CHB)
ClinicalMultiple ongoing programs
Key Facts
Indication
Chronic Hepatitis B (CHB)
Phase
Clinical
Status
Multiple ongoing programs
Company
About Amoytop Biotech
A Chinese biopharma company developing and commercializing long-acting recombinant protein drugs for hepatitis, oncology, and immunotherapy.
View full company profileTherapeutic Areas
Other Chronic Hepatitis B (CHB) Drugs
| Drug | Company | Phase |
|---|---|---|
| CARG-201 | CaroGen | Pre-clinical |
| Anti-HBVxCD3 | Ancora Bio | Preclinical |
| VIR-2218 + VIR-3434 | Vir Biotechnology | Phase 2 |
| Pevifoscorvir sodium (ALG-000184) | Aligos Therapeutics | Phase 2 |
| ALG-125755 | Aligos Therapeutics | Phase 1 |